EUVIMEDEUVIMED entdecken
Crossref

Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy

Joanna A Krupka iD, Alimu Dayimu iD, Daniel J Hodson iD

Journal of Clinical Oncology · 01.06.2026 · 44 (16) · 1558-1559

DOI: 10.1200/jco-26-00314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.06.2026. Verfasst von Joanna A Krupka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Joanna A. Krupka, MB PhD, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom, Department of Haematology, University of…. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Joanna A. Krupka, MB PhD, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom, Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Alimu Dayimu, PhD, Cambridge Cl…

ORCID-Profile: Joanna A Krupka, Alimu Dayimu, Daniel J Hodson

Zitieren

APA

Krupka, J. A., Dayimu, A., & Hodson, D. J. (2026). Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy. Journal of Clinical Oncology, 44(16), 1558-1559. https://doi.org/10.1200/jco-26-00314

Vancouver

Krupka JA, Dayimu A, Hodson DJ. Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy. Journal of Clinical Oncology. 2026;44(16):1558-1559. doi:10.1200/jco-26-00314

BibTeX
@article{Krupka2026,
  author = {Krupka, Joanna A and Dayimu, Alimu and Hodson, Daniel J},
  title = {Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {16},
  pages = {1558--1559},
  doi = {10.1200/jco-26-00314}
}
Kostenlos starten →